Yiviva
PrivateLast Round
Series A
Feb 21, 2018
Total Funding Raised
$7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Yiviva is a biotechnology company that develops multi-target therapeutics from botanical medicines to treat complex, aging-associated diseases, with a focus on cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Yiviva Comparables
Compare Yiviva with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HUTCHMED (China) Limited | 78% | |
| Tvardi | 71% | |
| Can Fite Biopharma Ltd ADR | 64% | |
Yiviva Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 21, 2018 |
Yiviva Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asian Fund for Cancer Research | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 82% MoM, reaching 5.7K.
- Mar 3, 2026
Monthly visitors increased 44% MoM.
Yiviva Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Yiviva's valuation, stock price, and market status.